Nah, no RS.
No, we haven't seen the upfront money yet. Reserving judgement until then.
Increasing the share ceiling does not necessarily mean a very large raise is coming. It is preparation for the exercise of the employee stock options and possibly is required to make progress on one or more advanced negotiations.
For example, if there is a potential pharma partner out there who wants to make an equity investment of $100M dollars at $1.00/share as part of a development deal, Leo would need 100M shares of headroom. He obviously can't move forward on a deal like that if he only has 70-80M shares of headroom approved.
Obviously that type of deal would technically entail some "dilution", but I don't consider it bad if it brings us from $0.18 to $1.00 and beyond.
I think some have to understand the CTIX we once loved and dreamed of is gone. That train went off the tracks in a blaze of glory and failure. Re-frame your expectations and embrace IPIX for the 10x or 20x investment it is from here. You can make a lot of money from these prices. Beyond that, hope for a gigantic Kevetrin deal.
News 
Market Data 
Discover 
